Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-30

Clinical Trial Update: A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy of PCSK-9 Inhibitors in Delaying the Progression of Calcified Aortic Valve Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase, multicenter randomized trial evaluating whether PCSK-9 inhibitors can slow the progression of calcific aortic valve disease in patients with aor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PCSK-9 inhibitors

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Aortic Stenosis, PCSK9 Inhibitor | EARLY_Phase 1 | Status: NOT_YET_RECRUITING